Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. - Wikidata - wikimedia - TriplyDB

Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.

Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.

http://www.wikidata.org/entity/Q34987136

about

Advances in dosimetry and biological predictors of radiation-induced esophagitis Complications from Stereotactic Body Radiotherapy for Lung Cancer Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer.Different definitions of esophagus influence esophageal toxicity prediction for esophageal cancer patients administered simultaneous integrated boost versus standard-dose radiation therapy Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors.Esophagus and Contralateral Lung-Sparing IMRT for Locally Advanced Lung Cancer in the Community Hospital Setting.Predictors for Severe Acute Esophagitis in Lung Cancer Patients Treated with chemoradiotherapy: a systematic review.Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.Prevention of radiation esophagitis by polaprezinc (zinc L-carnosine) in patients with non-small cell lung cancer who received chemoradiotherapy Infrequent chemoradiation-induced acute esophagitis in the Asian population: A meta-analysis of published clinical trials for unresectable stage III non-small cell lung cancer Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer.Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer.Limiting the risk of cardiac toxicity with esophageal-sparing intensity modulated radiotherapy for locally advanced lung cancers PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial.Nutrition support and dietary interventions for patients with lung cancer: current insights.Radiation-induced esophagitis in lung cancer.Proton Beam Therapy for Non-Small Cell Lung Cancer: Current Clinical Evidence and Future Directions.Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients With Cancer: A Systematic Review.Acute radiation oesophagitis associated with 2-deoxy-2-[18F]fluoro-d-glucose uptake on positron emission tomography/CT during chemo-radiation therapy in patients with non-small-cell lung cancer.Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study.Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation?Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs.Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer.The clinical characteristics and manifestations of cytomegalovirus esophagitis.Clinical Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer.Radiotherapy Dosing for Locally Advanced Non-Small Cell Lung Carcinoma: "MTD" or "ALARA"?Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.Effect of compound Zhuye Shigao Granule ( ) on acute radiation-induced esophagitis in cancer patients: A randomized controlled trial.Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels.Dosimetric factors associated with weight loss during (chemo)radiotherapy treatment for lung cancer.Positron Emission Tomography-Adjusted Intensity Modulated Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.Can the probability of radiation esophagitis be reduced without compromising lung tumor control: A radiobiological modeling study.Improving radiotherapy planning for large volume lung cancer: a dosimetric comparison between hybrid-IMRT and RapidArc.Decision analytic modeling for the economic analysis of proton radiotherapy for non-small cell lung cancer.Breaking the dose ceiling: proton therapy for locally advanced non-small cell lung cancer.A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer.[Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients].Therapeutic effect of dental pulp stem cell transplantation on a rat model of radioactivity-induced esophageal injury.

P2860

Q26766530-C20D77FA-E89C-4B54-B862-C7F5DBF28EB4 Q26995851-8F77A1F3-384E-418A-8FF0-B2FAAFC2ACE2 Q33597464-BA394516-B39D-4D8F-8A35-32945560A1D7 Q33669384-F6E8B32D-1BD1-43AB-80FF-FF932C9F054B Q34623353-3FF63299-BE1C-4AF3-989E-6CF4777E3123 Q35768924-2E714763-9A95-4EEF-AF1B-BA60ECA7212F Q36061153-6227B338-F82B-4A31-94F3-AD7C58FEB4D3 Q36196702-3BF40F45-0E20-46C9-ACAC-4029AA52B6C4 Q36317904-EAEF0D47-9653-4DD7-81D6-954A83CDB70B Q36439428-EC59C9A1-7A66-45F8-BD9E-225BF9E967FE Q36570250-F539B56C-9DE2-4A41-86A6-2FF5672816EC Q36724932-807A107D-4FB5-4211-A3F2-B96BA6C2F59A Q36829707-3BAB6087-F930-4D79-BC0A-CF6C9BACEF9F Q37417131-DDE476B0-200A-4414-B41E-70AD59A4E23F Q37643539-1316C856-0BAE-4548-AB8E-B0BFE3334F84 Q37643563-CE83B0CB-E764-4599-8AD5-E2EACBEE811A Q38543109-5D917C8E-2C73-47CD-AD8B-F9191AFF7674 Q38617589-EC117869-B1D6-4737-A564-E330D264F2AE Q38671608-8725B3F0-C83D-43F9-AD64-FF9BEAF86DA1 Q38867263-583BE1E6-2044-4E11-9624-E4B8DA330599 Q40610439-013F3E4F-37B9-4F8F-BDB9-6C55CE0F205D Q41035061-ECFEF33D-28A9-4DBF-ADEA-7FF1BE70F30F Q41039681-6A3C026E-C559-4130-9D73-7FA4985B76D1 Q41349096-126A74DA-E7F4-4320-9BD6-6340D52B8704 Q41961044-CEB08687-F826-4A25-AFC6-AE51D2DFF59C Q42363788-F70E1A4A-5A95-41BE-8B50-91513D194E26 Q43677664-4F742781-7DBE-432A-92DE-0F9CB34FE4A9 Q47099923-C51EC7DC-8454-4987-AA71-72D6F23E1BBC Q47245574-ED57E169-3A0E-41D2-A14E-D964CF39C44E Q47342475-E39488A0-89EC-4422-88FE-771B1664CD62 Q47442921-AE6B5CA0-4FB8-4B13-B19D-DAEC8C3085BB Q47777467-43EA884B-17FE-4606-9CB7-AD6F8537C24F Q52855166-BD968AC3-65C7-4B2E-82C0-37ADF1B6B36E Q52984769-1D830FEC-9721-4E79-B2BF-5E48D0D285E6 Q53394592-26E3F876-8092-4AE3-A8C2-050EFD1BDE27 Q55010544-04CB5170-20EE-42A3-B5D7-BDA6A3EF1231 Q55036513-4581D5A3-8E6B-42D7-83AE-8E67C08AD12B Q55279852-10134F05-CB2B-4D89-AC1A-769A76A81D3D Q55464352-CC7B6584-F343-4909-B575-73F30E5CB249 Q55518406-88ACB74E-BE83-4D21-86B0-967C8366D7C9

P2860

Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.

http://www.wikidata.org/entity/Q34987136

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Predicting esophagitis after c ...... al patient data meta-analysis.

@ast

Predicting esophagitis after c ...... al patient data meta-analysis.

@en

Predicting esophagitis after c ...... al patient data meta-analysis.

@nl

type

label

Predicting esophagitis after c ...... al patient data meta-analysis.

@ast

Predicting esophagitis after c ...... al patient data meta-analysis.

@en

Predicting esophagitis after c ...... al patient data meta-analysis.

@nl

prefLabel

Predicting esophagitis after c ...... al patient data meta-analysis.

@ast

Predicting esophagitis after c ...... al patient data meta-analysis.

@en

Predicting esophagitis after c ...... al patient data meta-analysis.

@nl

P1433

Q34987136-200C7FCD-6259-4A41-A127-81CB3EBD2466

P1476

Q34987136-540EE4AA-D136-4DB7-A742-21B827AEF017

P2093

Q34987136-001ED9D0-1EAE-49B8-9897-E32E4AB46EB3

Q34987136-34495C28-1B87-4AC3-885E-AAE76D982931

Q34987136-38CA26C9-3018-447F-9FF1-00871DEEAC9A

Q34987136-4AD71125-4287-4B8E-B562-487F3E2BDA9C

Q34987136-5DBD7C35-B374-4F3C-816C-58A15FA9401F

Q34987136-5E7A44AE-2699-4CD1-BD49-637AB90B2F2D

Q34987136-64B58D94-BF0C-45A4-B4BB-3BF47903DE2C

Q34987136-68D73A2C-D35D-4539-8CAC-20EDD590B3CE

Q34987136-6C2AB272-2828-4CA5-A58B-3368C0575AB0

Q34987136-9A139D19-AAB3-455C-95AA-888DA4B93E27

P304

Q34987136-E3AA17C8-475B-4577-96A7-5669E21475F0

P31

Q34987136-E7516173-7C05-4BFB-82CE-AC0EC3200B75

Q34987136-f2450631-8803-4ebb-b343-c005e293425a

P356

Q34987136-99F89EB8-F0F0-4F4E-B4D1-DCFD51E00FA0

P407

Q34987136-E9423668-8079-4848-8975-150EA6AB7575

P433

Q34987136-94E11065-194B-476C-AEA1-7771C876D585

P478

Q34987136-51BD7C53-3625-4113-ACD0-B2B75E731289

P50

Q34987136-1DA46452-A269-41C3-9104-3B37A6A53933

Q34987136-248CFBD1-2559-4076-BEE2-98BAD5F2935B

Q34987136-460463ED-1E21-4B4E-BFC4-3E4DD482B401

Q34987136-71AB8819-617E-4931-A9B4-16E4969E4369

Q34987136-FB96BB31-1F85-4B82-9C4D-ED9CBA0F0F7D

P577

Q34987136-4BB25A85-4186-4C15-A4E2-45404D078007

P698

Q34987136-82322C83-F822-4328-AA4B-1831AD311FDF

P921

Q34987136-7EB5DD05-02FB-4160-81D5-4B92082A4DBE

Q34987136-D1EE68DA-5296-4A7D-9BBD-C42D5636D7CE

Q34987136-DC76125B-4B2B-48DF-B4CF-5A4DAFD8E003

P356

J.IJROBP.2013.07.029

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Predicting esophagitis after c ...... ual patient data meta-analysis

@en

P2093

Andrew Warner

http://www.w3.org/2001/XMLSchema#string

David A Palma

http://www.w3.org/2001/XMLSchema#string

George Rodrigues

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Bradley

http://www.w3.org/2001/XMLSchema#string

Jose Belderbos

http://www.w3.org/2001/XMLSchema#string

Lawrence B Marks

http://www.w3.org/2001/XMLSchema#string

Marta Moreno-Jiménez

http://www.w3.org/2001/XMLSchema#string

Núria Rodríguez de Dios

http://www.w3.org/2001/XMLSchema#string

R Bryan Barriger

http://www.w3.org/2001/XMLSchema#string

Ramesh Rengan

http://www.w3.org/2001/XMLSchema#string

P304

690-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2013.07.029

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24035329

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy